Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688291
What this trial is testing
A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy
Who this might be right for
Esophageal Squamous Carcinoma Cell
Beijing GoBroad Hospital 40